Paranoid Schizophrenia (Delusional Disorder)

06/01/2009 - "The patient was cured with typical and atypical neuroleptic agents with previously stated diagnosis of paranoid schizophrenia, but no evident recovery was noticed. "
01/01/2013 - "To study changes in attention and executive functions during psychopharmacotherapy in patients with paranoid schizophrenia, we have examined 120 patients with a first episode of paranoid schizophrenia treated with typical and atypical neuroleptics. "
10/01/2007 - "The aim of the present study was to study sociodemographic profile, clinical parameters including comorbidity, usefulness of antipsychotics especially atypicals, family history, and follow-up rates for delusional disorder. "
01/01/2015 - "[Lipid spectrum changes and ECG in patients with paranoid schizophrenia in the course of therapy with atypical antipsychotics]."
09/01/2013 - "[Association polymorphic variants of GRIN2B gene with paranoid schizophrenia and response to common neuroleptics in Russians and Tatars from Bashkortostan Republic]."

01/01/1993 - "Some reports indicate that at least pimozide may be effective in delusional disorder as well. "
02/01/1998 - "1. The effects of pimozide on the psychopathology of delusional disorder were studied. "
02/01/1998 - "Effects of pimozide on the psychopathology of delusional disorder."
02/01/1993 - "A case of querulous-litigious delusional disorder successfully treated with low-dose pimozide is reported. "
10/01/1992 - "We believe pimozide's established benefit in the treatment of delusional disorders warrants its consideration in alleviating other delusions, including "the delusion of doubles.""

01/01/2008 - "Fourteen patients with paranoid schizophrenia (ICD-10, F20.0) were examined twice during 4,5-5 months, first--at the acute episode and second--at the period of development of remission during the treatment with olanzapine. "
10/01/2011 - "Twenty-two in-patients of a psychiatric university ward with the monodiagnosis of paranoid schizophrenia (ICD-10: F20.0), who received a monotherapy of olanzapine were included in this study. "
07/01/2014 - "We report a 38-year-old lady suffering from persistent delusional disorder who was prescribed olanzapine. "
05/01/2008 - "Successful treatment of delusional disorder of the somatic type or "delusional parasitosis" with olanzapine."
07/01/2007 - "We report, we believe for the first time in India, two cases of tardive oculogyric crisis in patients of schizophrenia, paranoid subtype (DSM IV code 295.30) during olanzapine therapy. "

04/01/2012 - "In our study with a diagnosis of paranoid schizophrenia treated with risperidone for 14 years and operated with the diagnosis of pituitary macroadenoma, a 32-year-old female patient is presented in the light of the literature examining the framework of the history of disease. "
07/01/1998 - "This preliminary study describes a case of a male patient who developed gynaecomastia and sexual difficulties whilst taking risperidone for chronic paranoid schizophrenia. "
01/01/2014 - "A 19-year-old Caucasian man was admitted to the Department of Psychiatry with paranoid schizophrenia and risperidone was administered in a gradually increasing dose up to 8 mg/day. "
01/01/2011 - "We present the case of a woman with paranoid schizophrenia who was receiving oral risperidone. "
05/01/2010 - "We report on a 37-year-old female patient who was given risperidone to treat an acute delusional disorder. "

01/01/2013 - "A considerable overlap exists between BDD and other psychiatric disorders such as OCD, anxiety, and delusional disorder, and this comorbidity should be considered in evaluation, management, and long-term follow-up of the disorder. "
10/01/2006 - "The difficulty to draw a discrete boundary between BDD and a delusional disorder of somatic type is highlighted."
04/01/1998 - "These data further suggest that the delusional variant of BDD (delusional disorder, somatic type) may also respond to SRIs. "
06/01/1995 - "The double coding allowed for BDD acknowledges that BDD and its delusional disorder variant may constitute a single disorder; that allowed for OCD acknowledges that OCD may be delusional. "
01/01/1994 - "Thus, BDD may have a psychotic subtype that significantly overlaps with, and may even be the same disorder as, its delusional disorder variant. "

01/01/1996 - "Available data also suggest that serotonin reuptake inhibitors may be effective for delusional BDD (a type of delusional disorder, somatic type). "
09/01/1992 - "The authors suggest that body dismorphic disorder be classified with obsessive compulsive disorder, whatever the intensity of symptomatology, rather than with somatoform or delusional disorder, and treated with serotonin uptake inhibitors or neureptics that have been proven to be effective for the treatment of this disorder, such as pimozide."
02/01/2001 - "Available data suggest that the delusional variant of body dysmorphic disorder (BDD), a type of delusional disorder, may respond to serotonin reuptake inhibitors (SRIs) and that delusionality (lack of insight) in BDD may improve with SRI treatment. "

09/01/2014 - "The association of polymorphic variants of genes GRIA2 and GRIK2 with paranoid schizophrenia and response to therapy with haloperidol in Russian and Tatar of the Republic of Bashkortostan was conducted in the present study. "
01/01/1964 - "[ON THE TREATMENT OF PARANOID SCHIZOPHRENIA WITH HALOPERIDOL]."
01/01/2010 - "A 73-year-old Caucasian woman with no history of neuromuscular disorder, treated for chronic delusional disorder for the last ten years, received two injections of long-acting haloperidol. "
06/01/2002 - "(1) A relatively small dose of haloperidol was more effective for delusional disorder than for schizophrenia. "
10/01/1996 - "All of them were clinically indistinguishable from paranoid schizophrenia, but the psychotic symptoms often resolved promptly with the cessation of cough mixture use or a small dose of haloperidol. "

07/01/1993 - "Based on a preliminary study in 10 patients with essentially paranoid schizophrenia, treated with fluoxetine 20 mg per day, the author observed an improvement in sadness, sleep, death wishes in 7 patients, without exacerbation of delusions. "
06/01/2004 - "[Use of fluoxetine in somatic delusional disorder]."
09/01/2000 - "In this paper, 12 cases of patients with paranoid schizophrenia who developed social phobia during clozapine treatment are reported, and their response to fluoxetine augmentation is assessed. "

07/01/2014 - "We conclude that amisulpride is effective in disorganized as well as in paranoid schizophrenia, but that symptom reduction in the disorganized subtype is less pronounced."
05/01/2006 - "We report on a case of a patient with paranoid schizophrenia, who still presented negative and depressive symptoms during treatment with amisulpride for more than 6 weeks. "
08/01/2000 - "In a multicentre, double-blind, flexible-dose study, 199 patients with paranoid schizophrenia or schizophreniform disorders received haloperidol (10-30 mg/d) or amisulpride (400-1200 mg/d) for four months. "

07/01/2015 - "The research included 91 subjects, right handed, from 30 to 53 years old, who were classified into three groups: inpatients with paranoid schizophrenia in remission (n=31), inpatients with schizoaffective disorder in remission (n=30) and healthy subjects (n=30). "
12/30/2011 - "For this purpose, DTI was used to assess white matter integrity in patients with paranoid schizophrenia (n=25) and psychotic bipolar mania (n=18) who had been treated with standard pharmacotherapy for fewer than 5 days at the time of study, as well as in normal controls (n=30). "

07/01/2011 - "Here, we are reporting a case of an elderly female patient with chronic paranoid schizophrenia showing short-term remission in paranoid symptoms with injectable lorazepam."
01/01/2010 - "A 73-year-old Caucasian woman with no history of neuromuscular disorder, treated for chronic delusional disorder for the last ten years, received two injections of long-acting haloperidol. "
05/01/2014 - "Effectiveness of long-acting injectable antipsychotics in delusional disorders with nonprominent hallucinations and without hallucinations."
12/01/2013 - "The Task Force recommends as first-line choice, the use of long-acting injectable (LAI) second-generation antipsychotics in patients with schizophrenia, schizoaffective disorder and delusional disorder. "

11/01/1986 - "Although extremely rare, autocastration usually occurs in men with chronic paranoid schizophrenia, with a long history of delusions of sexual guilt which can only be relieved by castration. "

08/01/2013 - "Comparative efficacy and acceptability of existing pharmacotherapies for delusional disorder: a retrospective case series and review of the literature."
12/01/2006 - "Reported herein is a case of WD in a young man presenting persistent delusional disorder of organic etiology, which resolved entirely after 4 months of combined pharmacotherapy. "
01/01/2006 - "Pharmacotherapy of delusional disorders in the context of offending and the potential for compulsory treatment."
11/01/2005 - "A 52-year-old patient with treatment-resistant paranoid schizophrenia developed severe parkinsonian features after more than 20 years of antipsychotic drug therapy. "
07/01/1991 - "[Principles of chemotherapy of paranoid schizophrenia]."

04/26/1974 - "Nursing care study: paranoid schizophrenia."

03/01/1998 - "Delusional disorder in a boy with phenylketonuria and amine metabolites in the cerebrospinal fluid after treatment with neuroleptics."
10/01/2007 - "Exacerbation of paranoid schizophrenia in a psoriatic patient after treatment with cyclosporine A, but not with etanercept."
09/02/2006 - "A 45-year-old man with paranoid schizophrenia repeatedly developed hyponatraemia due to the syndrome of inappropriate antidiuretic hormone secretion (SIADH), both after treatment with haloperidol and after taking quetiapine. "